285 related articles for article (PubMed ID: 11698706)
1. Transmission of zidovudine resistant strains of HIV-1: the first wave.
Blower S
AIDS; 2001 Nov; 15(17):2317-8. PubMed ID: 11698706
[No Abstract] [Full Text] [Related]
2. A fossil record of zidovudine resistance in transmitted isolates of HIV-1.
Kuritzkes DR
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13485-7. PubMed ID: 11717419
[No Abstract] [Full Text] [Related]
3. Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.
Goudsmit J; Weverling GJ; van der Hoek L; de Ronde A; Miedema F; Coutinho RA; Lange JM; Boerlijst MC
AIDS; 2001 Nov; 15(17):2293-301. PubMed ID: 11698703
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral Resistance Mutations (revised April 2001).
;
HIV Clin Trials; 2001; 2(4):346-55. PubMed ID: 11590539
[No Abstract] [Full Text] [Related]
5. Insertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms.
Winters MA; Merigan TC
Antimicrob Agents Chemother; 2005 Jul; 49(7):2575-82. PubMed ID: 15980322
[No Abstract] [Full Text] [Related]
6. Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates.
Vanhems P; Gaudet R; Hirschel B; Imrie A; Conway B; Rouleau D; Vizzard J; Perrin L; Cooper DA; Yerly S
AIDS; 2000 May; 14(8):1065-7. PubMed ID: 10853993
[No Abstract] [Full Text] [Related]
7. Algorithm specification interface for human immunodeficiency virus type 1 genotypic interpretation.
Betts BJ; Shafer RW
J Clin Microbiol; 2003 Jun; 41(6):2792-4. PubMed ID: 12791935
[No Abstract] [Full Text] [Related]
8. [Evolution of HIV resistance mutations in the Valme referral center].
Nogales MC; Castro C; Martín-Mazuelos E
Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):159. PubMed ID: 17288915
[No Abstract] [Full Text] [Related]
9. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
Descamps D; Chaix ML; Montes B; Pakianather S; Charpentier C; Storto A; Barin F; Dos Santos G; Krivine A; Delaugerre C; Izopet J; Marcelin AG; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Tamalet C; Cottalorda J; Desbois D; Calvez V; Brun-Vezinet F; Masquelier B; Costagliola D;
J Antimicrob Chemother; 2010 Dec; 65(12):2620-7. PubMed ID: 20965891
[TBL] [Abstract][Full Text] [Related]
10. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.
Gallego O; Ruiz L; Vallejo A; Ferrer E; Rubio A; Clotet B; Leal M; Soriano V;
AIDS; 2001 Sep; 15(14):1894-6. PubMed ID: 11579258
[TBL] [Abstract][Full Text] [Related]
11. Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.
de Ronde A; van Dooren M; de Rooij E; van Gemen B; Lange J; Goudsmit J
AIDS; 2000 Nov; 14(16):2632-3. PubMed ID: 11101087
[No Abstract] [Full Text] [Related]
12. Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy.
Pellegrin I; Segondy M; Garrigue I; Izopet J; Montes B; Pellegrin JL; Reynes J; Massip P; Puel J; Fleury H
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):465-6. PubMed ID: 11141248
[No Abstract] [Full Text] [Related]
13. Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons.
Garcia-Lerma JG; Nidtha S; Blumoff K; Weinstock H; Heneine W
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13907-12. PubMed ID: 11698656
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.
Soriano V
Antivir Ther; 1999; 4 Suppl 3():57-63. PubMed ID: 16021872
[TBL] [Abstract][Full Text] [Related]
15. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
[No Abstract] [Full Text] [Related]
16. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M
Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586
[TBL] [Abstract][Full Text] [Related]
17. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
Kuritzkes DR; Sevin A; Young B; Bakhtiari M; Wu H; St Clair M; Connick E; Landay A; Spritzler J; Kessler H; Lederman MM
J Infect Dis; 2000 Feb; 181(2):491-7. PubMed ID: 10669331
[TBL] [Abstract][Full Text] [Related]
18. Current insights into reverse transcriptase inhibitor-associated resistance.
Wainberg MA; White AJ
Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
[No Abstract] [Full Text] [Related]
19. Differences in the frequency of resistance to antiretroviral drug classes among human immunodeficiency virus type 1 clinical isolates.
Campo RE; Lichtenberger PN; Rosa I; Suarez G; Rivera FA; Rodriguez AE; Jayaweera DT; Wahlay NA; Kolber MA
J Clin Microbiol; 2003 Jul; 41(7):3376-8. PubMed ID: 12843097
[TBL] [Abstract][Full Text] [Related]
20. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
Miranda LR; Götte M; Liang F; Kuritzkes DR
Antimicrob Agents Chemother; 2005 Jul; 49(7):2648-56. PubMed ID: 15980332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
